3 Questions to Department of Health and Social Care tabled by Holly Lynch
|12 May 2020, 12:38 p.m.||Endoscopy: Coronavirus||Holly Lynch|
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the resumption of endoscopy service provision during the covid-19 outbreak.
Answer (Edward Argar)
The National Health Service has continued to provide urgent and emergency services throughout the COVID-19 pandemic. To ensure patient safety and continuation of service, local systems and Cancer Alliances are providing diagnostic and surgical provision through cancer hubs and contracted independent sector hospitals.
Diagnostics and treatment are actively being brought back up to pre-pandemic levels and referrals into services are being encouraged through campaigns such as the ‘Open for Business’ media campaign to encourage people with potentially serious health issues, such as cancer, to continue to seek medical advice and attend essential appointments.
|1 May 2019, 4:06 p.m.||Ehlers-Danlos Syndrome||Holly Lynch|
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the diagnosis time for patients with Ehlers–Danlos syndrome.
Answer (Caroline Dinenage)
Ehlers-Danlos Syndromes (EDS) are a group of rare inherited connected tissue disorders, affecting around one in 20,000 people. EDS can go undiagnosed, or misdiagnosed, for many years.
Building upon the success of the 100,000 Genomes Project, in which EDS was included as part of the rare disease arm, the NHS Genomics Medicine Service (GMS) was launched in October 2018. The GMS brings together existing clinical genetics services and new genomic laboratory infrastructure to provide consistent and equitable access to genomic medicine.
The National Genomic Test Directory which underpins the GMS was updated in March 2019 and specifies which genomic tests are commissioned by the National Health Service in England, the technology by which they are available, and the patients who will be eligible to access a test. EDS with a likely monogenic cause is included in the National Test Directory.
|1 May 2019, 4:03 p.m.||Ehlers-Danlos Syndrome||Holly Lynch|
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the waiting time for patients with Ehlers–Danlos syndromes to see a specialist.
Answer (Caroline Dinenage)
Services for patients with Ehlers–Danlos syndromes (EDS) are provided at a local and national level. NHS England commissions services for patients, adults and children, with EDS from specialist rheumatology centres. A Complex EDS service for adults and children is being delivered at two centres in England, London North West University Healthcare Trust and Sheffield Children’s NHS Foundation Trust. The two expert centres ensure that a correct diagnosis of EDS has been made and investigate complex cases of EDS. Some patients may also be seen in more local rheumatology services, which are commissioned by clinical commissioning groups.
From October 2018, the National Genomic Test Directory has been in place and specifies the genomic tests that will be commissioned directly by NHS England and the patients who will be eligible to access this testing for diagnostic purposes. EDS with a likely monogenic cause is included in the National Test Directory.